For more information on CollaGenex please visit CollaGenex's website at http://www.collagenex.com, which does not form part of this press release.
Forward Looking Statements
Statements in this press release regarding management's future
expectations, beliefs, intentions, goals, strategies, plans or prospects
may constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements can be
identified by terminology such as "anticipate," "believe," "could," "could
increase the likelihood," "estimate," "expect," "intend," "is planned,"
"may," "should," "will," "will enable," "would be expected," "look
forward," "may provide," "would" or similar terms, variations of such terms
or the negative of those terms. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors including those
risks, uncertainties and factors referred to in the Company's Quarterly
Report on Form 10-K for the year ended December 31, 2007 filed with the
Securities and Exchange Commission under the section "Risk Factors," as
well as other documents that may be filed by CollaGenex from time to time
with the Securities and Exchange Commission as well as related to the
satisfaction of the closing conditions in the merger agreement. As a result
of such risks, uncertainties and factors, the Company's actual results may
differ materially from any future results, performance or achievements
discussed in or implied by the forward-looking statements contained herein.
CollaGenex is providing the information in this press release as of this
date and assumes no obligations to up
|SOURCE Galderma Pharma S.A.|
Copyright©2008 PR Newswire.
All rights reserved